DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)
South Korea · Delayed Price · Currency is KRW 18,340
-150 (-0.81%)
At close: Feb 11, 2026
DongKook Pharmaceutical Revenue
DongKook Pharmaceutical had revenue of 226.81B KRW in the quarter ending September 30, 2025, with 12.91% growth. This brings the company's revenue in the last twelve months to 894.93B, up 13.41% year-over-year. In the year 2024, DongKook Pharmaceutical had annual revenue of 812.17B with 11.10% growth.
Revenue (ttm)
894.93B
Revenue Growth
+13.41%
P/S Ratio
0.92
Revenue / Employee
725.82M
Employees
1,233
Market Cap
820.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 812.17B | 81.17B | 11.10% |
| Dec 31, 2023 | 730.99B | 69.35B | 10.48% |
| Dec 31, 2022 | 661.65B | 67.45B | 11.35% |
| Dec 31, 2021 | 594.19B | 35.09B | 6.28% |
| Dec 31, 2020 | 559.10B | 76.82B | 15.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.06T |
| Chong Kun Dang Pharmaceutical | 1.68T |
| Dong-A Socio Holdings | 1.40T |
| Boryung | 1.03T |
| Huons Global | 825.44B |
| Dong-A ST | 770.63B |
| JW Pharmaceutical | 764.21B |
| Ildong Pharmaceutical | 575.66B |